When Kay Zedd Kesser looks around her family tree, she sees pancreatic cancer everywhere. But screening saved Kay’s life.
With a focus on targeting cell metabolism, Dr. Anup Kasi leads a clinical trial of a new agent in combination with gemcitabine.
In combination with radiation treatment, researchers are testing a new drug that causes DNA damage to make that treatment more effective.
Researchers are comparing chemotherapy regimens for effectiveness before surgery, and whether switching treatments makes a difference.